Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BeEAM vs BEAM Conditioning for ASCT in Lymphoma
NCT02278796Phase 2Completed
- Sponsor
- Insel Gruppe
- Start
- Apr 2015
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of bendamustine in diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), mantle cell lymphoma (MCL), sponsored by Insel Gruppe. Started Apr 2015; status: completed.
02
Drugs
bendamustine
03
Conditions
diffuse large B-cell lymphoma (DLBCL)follicular lymphoma (FL)mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on NCT02278796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02278796.